Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
05/2005
05/19/2005CA2544848A1 Method of preventing virus: cell fusion by inhibiting the function of the fusion initiation region in rna viruses having class i membrane fusogenic envelope proteins
05/19/2005CA2544368A1 Methods of therapy for b cell-related cancers
05/19/2005CA2544364A1 Use of antagonist anti-cd40 antibodies for treatment of chronic lymphocytic leukemia
05/19/2005CA2544214A1 Hla-dr-binding antigen peptide derived from wt1
05/19/2005CA2543489A1 Human anti il-15 antibody 146b7 inducing monocytes apoptosis, therapeutical uses thereof
05/19/2005CA2543193A1 Removal of high molecular weight aggregates using hydroxyapatite chromatography
05/19/2005CA2543115A1 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
05/19/2005CA2542886A1 Enhanced b cell cytotoxicity of cdim binding antibody
05/19/2005CA2484459A1 Anti cd44 antibodies for eradicating stem cells
05/19/2005CA2450289A1 Method of producing an antibody to epidermal growth factor receptor
05/18/2005EP1531332A1 Analysis and typing of monoclonal proteins by capillary electrophoresis and immunoshift
05/18/2005EP1531162A1 Adenocarcinoma specific antibody SAM-6, and uses thereof
05/18/2005EP1531160A1 Recovery of a heat shock protein
05/18/2005EP1530973A2 Methods for inducing T cell tolerance to a tissue or organ graft
05/18/2005EP1530632A2 Growth factor which acts through erb b-4 rtk
05/18/2005EP1530630A2 Novel lipases and uses thereof
05/18/2005EP1530586A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
05/18/2005EP1530584A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses
05/18/2005EP1530580A2 Humanized gm-csf antibodies
05/18/2005EP1530579A2 Recombinant antibodies, and compositions and methods for making and using the same
05/18/2005EP1530484A1 A method of immunomodulation
05/18/2005EP1161530B1 Protein for blocking platelet adhesion
05/18/2005EP1145011B1 Compositions and methods for the diagnosis and treatment of tumor
05/18/2005EP0894141B1 Hybrid proteins which form heterodimers
05/18/2005CN1617926A A structure for presenting desired peptide sequences
05/18/2005CN1617922A Composition of antibody specifically binding to CD20
05/18/2005CN1617888A Bispecific antibody DNA constructs for intramuscular administration
05/18/2005CN1617887A Corticotropin releasing factor receptor 2 agonists
05/18/2005CN1617886A Corticotropin releasing factor receptor 2 agonists
05/18/2005CN1617885A Corticotropin releasing factor receptor 2 agonists
05/18/2005CN1617884A Beta-amyloid binding factors and inhibitors thereof
05/18/2005CN1616485A SARS coronavirus structure protein ORF3 and its use
05/18/2005CN1202261C Methods for making recombinant cells
05/18/2005CN1202252C Recombination proteins of Pakistani strain of hepatitis E and their use in diagnostic method and vaccines
05/18/2005CN1202132C IgG Fab-BPI fusion protein and DNA sequence thereof
05/18/2005CN1202128C Immunogenicity of modified protein
05/18/2005CN1201819C Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens
05/18/2005CN1201818C Vaccine
05/17/2005US6894157 Guanylate binding protein (GBP-1) as inhibitor of cell proliferation and molecular marker for the determination of the stage of cellular differentiation
05/17/2005US6894155 Immumodulatory protein for use in the treatment of nervous system, skin and immunological disorders
05/17/2005US6894149 Monoclonal/polyclonal human leukocyte antigen (HLA) antibodies for use in the treatment of leukemias, lymphomas, or solid tumors of ovaries; antitumor agents; apoptosis
05/17/2005US6894148 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders
05/17/2005US6894147 Intermediate conductance calcium-activated potassium channels (IK1)
05/17/2005US6893858 Human kcnq5 potassium channel, methods and compositions thereof
05/17/2005US6893845 Surface expression libraries of heteromeric receptors
05/17/2005US6893844 DNA encoding a new human hepatoma derived growth factor and producing method thereof
05/17/2005US6893843 Nucleic acids
05/17/2005US6893841 Nucleotide sequences coding polypeptide for use in tool in treatment of defects in protein transport
05/17/2005US6893838 DADD, death activator death domain protein
05/17/2005US6893813 Methods for treatment of HIV and other infections using a T cell or viral activator and anti-retroviral combination therapy
05/17/2005US6893639 Preparation and recovery of immunoglobulins; provide blood, suspend in ethanol, adjust hydrogen ion concentration, extract immunoglobulins using liquid-solid separation, remove impurities, deactivate viruses, recover immunoglobulins
05/17/2005US6893638 Methods for treating b cell lymphoma using CD80-specific antibodies
05/17/2005US6893637 Method of treating fibrosis
05/17/2005US6893636 Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use thereof as therapeutics
05/17/2005US6893625 Mediating cytolysis; two light chains and two heavy chains; nonhuman variable region and human constant region; specifi-city for CD20 antigen bound by hybridoma HB9303 produced antibody
05/17/2005CA2375673C Dna sequences derived from the genome of the papillomavirus hpv39, their application to in vitro diagnostic and to the production of immunogen compositions
05/17/2005CA2248144C Horse endothelin-b receptor gene and gene products
05/17/2005CA2235845C Prostaglandin d synthase-specific monoclonal antibody
05/17/2005CA2234409C Transferrin receptor protein of moraxella
05/17/2005CA2182393C Dna mutagenesis by random fragmentation and reassembly
05/17/2005CA2115151C Tau/neurofilament protein kinases pk40 and pk36
05/12/2005WO2005043166A1 Diagnostic for uterine gland cancer and method of detecting gland cancer cell
05/12/2005WO2005042780A1 Phage antibodies to radiation-inducible neoantigens
05/12/2005WO2005042774A2 Method for linking sequences of interest
05/12/2005WO2005042746A1 Bacterial virulence factors and uses thereof
05/12/2005WO2005042743A2 Humanization of antibodies
05/12/2005WO2005042725A2 Liver cancer biomarkers
05/12/2005WO2005042714A2 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof
05/12/2005WO2005042711A2 Pain-associated gene pnpg1
05/12/2005WO2005042695A2 Lipoparticles comprising proteins, methods of making, and using the same
05/12/2005WO2005042582A1 Process for producing antibody
05/12/2005WO2005042581A2 Modified anti-cd52 antibody
05/12/2005WO2005042580A1 Anti-cd63 scfv antibody and use thereof
05/12/2005WO2005042579A1 Anti-sars virus antibody, hybridoma producing the antibody and immunoassay reagent using the antibody
05/12/2005WO2005042578A2 Antibody fab fragment specific for breast cancer
05/12/2005WO2005042564A1 Flagellin fusion proteins as adjuvants or vaccines and methods of use
05/12/2005WO2005042102A1 A protein involved in ovarian cancer
05/12/2005WO2005042029A2 Psma formulations and uses thereof
05/12/2005WO2005042028A2 Il-13 conjugated to an immunogen and uses thereof
05/12/2005WO2005042019A1 Anti-thymocyte antiserum and use thereof to trigger b cell apoptosis
05/12/2005WO2005042009A1 Therapeutic regimens for baff antagonists
05/12/2005WO2005041992A2 Colostrum compositions and methods
05/12/2005WO2005041877A2 Method of inhibiting rejection following organ transplantation
05/12/2005WO2005041862A2 Neutralizing antibodies against extracellular hexosaminidase for treatment of arthritis
05/12/2005WO2005019432A3 A novel gene and protein associated with angiogenesis and endothelial apoptosis
05/12/2005WO2005019269A3 Techniques and compositions for the diagnosis and treatment of cancer (muc1)
05/12/2005WO2005012530A3 Antagonists and agonists of ldcam and methods of use
05/12/2005WO2005007699A3 Human antibody molecules for il-13
05/12/2005WO2004082715A8 Concomitant drug as therapeutic agent for inflammatory bowel disease
05/12/2005WO2004071530A3 Identification of cellular polypeptides differentially expressed by tumor cells
05/12/2005WO2004068115A3 Assay method for group transfer reactions
05/12/2005WO2004029284A3 Efficient generation of stable expression cell lines through the use of scorable homeostatic reporter genes
05/12/2005WO2004007717A8 Proteomic screen to identify disease-related biological molecules and inhibitors thereto
05/12/2005WO2003085124A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/12/2005WO2001079525A3 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
05/12/2005US20050102712 Using chlorophyll biosynthesis enzyme as tool for identifying agents which enhance photosynthetic activity of plants
05/12/2005US20050101773 Genes required for viability and/or reproduction in c. elegans and their use in the development of anti-nematode agents
05/12/2005US20050101770 Humanized recombinant immunoglobulins for use in identifying modulators for prevention and treatment of autoimmune disorders
05/12/2005US20050101769 CD40-interacting and TRAF-interacting proteins
05/12/2005US20050101556 Genetic engineering; Alzheimer's disease; anticancer agents
1 ... 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 ... 1494